Concurrent down-regulation of Egr-1 and gelsolin in the majority of human breast cancer cells.

Abstract

Our results suggest that Egr-1 may be an important breast cancer marker and that an as yet uncharacterized pathway involved in Egr-1 and gelsolin expression exists which leads to breast cancer cell development.